SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing significant volatility and a steep sell-off after disclosing that Marvell canceled its purchase orders due to a confidentiality breach caused by public remarks from management. The community is sharply divided, with many retail investors expressing frustration over the lack of transparency while others view the dip as an opportunity to accumulate shares, betting on the long-term viability of the company's photonics technology.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk (SNDK) is surging toward record highs, driven by explosive AI-related demand for its NAND memory and intense speculation surrounding a potential stock split ahead of its upcoming earnings report. The community remains deeply divided, with bulls pointing to robust fundamentals and a 'memory supercycle,' while bears remain skeptical of the stock's parabolic valuation and fear an imminent correction.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is hitting record highs as market participants continue to aggressively chase AI momentum, with discussions heavily focused on sustained data center demand and the stock's role as a foundational infrastructure play. While some investors are wary of the stock's parabolic climb and valuation, the broader community remains fiercely bullish, viewing any minor pullbacks as buying opportunities amid a broader rally in the semiconductor sector.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

HTCO is seeing significant retail attention driven by high volatility and heavy short interest, leading traders to discuss the potential for a short squeeze despite skepticism surrounding the company's fundamentals and recent price action. The community remains divided, with some actively trading the sharp price swings while others warn of the risks associated with the stock's unpredictable performance.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is seeing significant market activity driven by the potential integration of its chips into future AI-agentic smartphone platforms and broader AI infrastructure. While the community is actively debating the stock's valuation and the company's long-term competitive positioning, investors are closely watching upcoming earnings as a potential catalyst to clear current overhead supply.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is experiencing significant community momentum as investors anticipate the official U.S. launch of its predictive betting platform, a move bolstered by recent strategic marketing partnerships. Market participants are actively discussing a potential squeeze driven by a tight float, high short interest, and the stock's positioning as a pure-play opportunity in the rapidly expanding predictive betting sector.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing high volatility as investors weigh the potential for government contract awards against frustration with management's communication regarding timelines and guidance. The community is focused on the company's drone integration with U.S. military platforms and remains split between optimism for future revenue growth and skepticism over the timing of major defense milestones.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as the company accelerates its New York flight campaign and secures key regulatory approvals for operations, fueling optimism among investors tracking its progress toward commercial launch. While community sentiment is heavily polarized between long-term supporters focused on these engineering milestones and skeptics pointing to high cash burn and technical volatility, traders are actively monitoring the stock's significant options activity and price action around key resistance levels.

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Inc

Coeptis Therapeutics is trending as investors anticipate the upcoming merger with Z Squared and a subsequent ticker change, with community members actively discussing the potential value of the spinoff and mining operations. Despite volatility and speculation regarding the timing of the deal, traders are closely monitoring volume spikes and short interest as they look for a breakout catalyst.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors following the release of positive Phase 3 clinical trial results, though the stock's price action has been marked by high volatility and intense debate among traders. While the community is actively discussing the company's long-term potential in gene-editing, significant disagreement persists over the efficacy of the data, the impact of potential dilution from an at-the-market offering, and the heavy influence of short sellers on the stock's movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tectonic Therapeutic (NASDAQ:TECX) Rating Lowered to "Strong Sell" at Wall Street Zen

Wall Street Zen cut shares of Tectonic Therapeutic from a "sell" rating to a "strong sell" rating in a report on Saturday...

Aberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECX

Aberdeen Group plc boosted its holdings in shares of Tectonic Therapeutic, Inc. (NASDAQ:TECX - Free Report) by 220.6% in the fourth quarter, according to the company in its most recent 13F filing...

Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,000 Shares of Stock

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) insider Marcella Ruddy sold 1,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $31.05, for a total value of $31,050.00. Following the sale, the insider directly...

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven analysts that are covering the company, MarketBeat Ratings...

Tectonic Therapeutic (NASDAQ:TECX) Insider Marcella Ruddy Sells 1,000 Shares

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) insider Marcella Ruddy sold 1,000 shares of Tectonic Therapeutic stock in a transaction on Wednesday, April 1st. The shares were sold at an...

Tectonic Therapeutic (NASDAQ:TECX) Shares Up 9.3%  - What's Next?

Tectonic Therapeutic (NASDAQ:TECX) Shares Up 9.3% - Here's What Happened...

First Light Asset Management LLC Makes New $3.18 Million Investment in Tectonic Therapeutic, Inc. $TECX

First Light Asset Management LLC acquired a new position in Tectonic Therapeutic, Inc. (NASDAQ:TECX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Braidwell LP Makes New $11.56 Million Investment in Tectonic Therapeutic, Inc. $TECX

Braidwell LP purchased a new position in Tectonic Therapeutic, Inc. (NASDAQ:TECX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the...

Tectonic Therapeutic (TECX) to Release Earnings on Thursday

Tectonic Therapeutic (NASDAQ:TECX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...

Tectonic Therapeutic (NASDAQ:TECX) Insider Marcella Ruddy Sells 10,000 Shares

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) insider Marcella Ruddy sold 10,000 shares of the stock in a transaction that occurred on Friday, March 6th. The shares were sold at an...

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.17	--	--	N/A
Q4 '25	-$1.11	-$1.03	6.97%	BEAT
Q3 '25	-$1.06	-$1.02	3.39%	BEAT
Q2 '25	-$0.98	-$1.07	-9.47%	MISSED
Q1 '25	-$1.09	-$0.93	14.36%	BEAT

TECX
Tectonic Therapeutic Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest TECX News

TECXTectonic Therapeutic Inc.